105 related articles for article (PubMed ID: 38743932)
1. Genetic assessment of IPMN for predicting concomitant pancreatic ductal adenocarcinoma.
Oi H; Hozaka Y; Akahane T; Fukuda K; Idichi T; Tanoue K; Yamasaki Y; Kawasaki Y; Mataki Y; Kurahara H; Higashi M; Tanimoto A; Ohtsuka T
Pancreas; 2024 May; ():. PubMed ID: 38743932
[TBL] [Abstract][Full Text] [Related]
2. Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype.
Ideno N; Ohtsuka T; Kono H; Fujiwara K; Oda Y; Aishima S; Ito T; Ishigami K; Tokunaga S; Ohuchida K; Takahata S; Nakamura M; Mizumoto K; Tanaka M
Ann Surg; 2013 Jul; 258(1):141-51. PubMed ID: 23532108
[TBL] [Abstract][Full Text] [Related]
3. Deep sequencing of cancer-related genes revealed GNAS mutations to be associated with intraductal papillary mucinous neoplasms and its main pancreatic duct dilation.
Takano S; Fukasawa M; Maekawa S; Kadokura M; Miura M; Shindo H; Takahashi E; Sato T; Enomoto N
PLoS One; 2014; 9(6):e98718. PubMed ID: 24897499
[TBL] [Abstract][Full Text] [Related]
4. Assessment of clonality of multisegmental main duct intraductal papillary mucinous neoplasms of the pancreas based on GNAS mutation analysis.
Tamura K; Ohtsuka T; Matsunaga T; Kimura H; Watanabe Y; Ideno N; Aso T; Miyazaki T; Ohuchida K; Takahata S; Ito T; Ushijima Y; Oda Y; Mizumoto K; Tanaka M
Surgery; 2015 Feb; 157(2):277-84. PubMed ID: 25530484
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of GNAS mutation in intraductal papillary mucinous neoplasm of the pancreas with concomitant pancreatic ductal adenocarcinoma.
Ideno N; Ohtsuka T; Matsunaga T; Kimura H; Watanabe Y; Tamura K; Aso T; Aishima S; Miyasaka Y; Ohuchida K; Ueda J; Takahata S; Oda Y; Mizumoto K; Tanaka M
Pancreas; 2015 Mar; 44(2):311-20. PubMed ID: 25479586
[TBL] [Abstract][Full Text] [Related]
6. Distinction of Invasive Carcinoma Derived From Intraductal Papillary Mucinous Neoplasms From Concomitant Ductal Adenocarcinoma of the Pancreas Using Molecular Biomarkers.
Tamura K; Ohtsuka T; Date K; Fujimoto T; Matsunaga T; Kimura H; Watanabe Y; Miyazaki T; Ohuchida K; Takahata S; Ishigami K; Oda Y; Mizumoto K; Nakamura M; Tanaka M
Pancreas; 2016 Jul; 45(6):826-35. PubMed ID: 26646266
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of GNAS and KRAS mutations in pancreatic cysts.
Lee LS; Doyle LA; Houghton J; Sah S; Bellizzi AM; Szafranska-Schwarzbach AE; Conner JR; Kadiyala V; Suleiman SL; Banks PA; Andruss BF; Conwell DL
JOP; 2014 Nov; 15(6):581-6. PubMed ID: 25435574
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic Ductal Adenocarcinoma Concomitant with Main Duct Type Intraductal Papillary Mucinous Neoplasm of the Pancreas: A Case Report.
Yonamine K; Koshita S; Kanno Y; Ogawa T; Kusunose H; Sakai T; Miyamoto K; Kozakai F; Okano H; Okada T; Oikawa M; Tsuchiya T; Sawai T; Noda Y; Ito K
Am J Case Rep; 2021 Sep; 22():e932565. PubMed ID: 34473678
[TBL] [Abstract][Full Text] [Related]
9. Multiregion whole-exome sequencing of intraductal papillary mucinous neoplasms reveals frequent somatic
Fujikura K; Hosoda W; Felsenstein M; Song Q; Reiter JG; Zheng L; Beleva Guthrie V; Rincon N; Dal Molin M; Dudley J; Cohen JD; Wang P; Fischer CG; Braxton AM; Noë M; Jongepier M; Fernández-Del Castillo C; Mino-Kenudson M; Schmidt CM; Yip-Schneider MT; Lawlor RT; Salvia R; Roberts NJ; Thompson ED; Karchin R; Lennon AM; Jiao Y; Wood LD
Gut; 2021 May; 70(5):928-939. PubMed ID: 33028669
[TBL] [Abstract][Full Text] [Related]
10. Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas.
Amato E; Molin MD; Mafficini A; Yu J; Malleo G; Rusev B; Fassan M; Antonello D; Sadakari Y; Castelli P; Zamboni G; Maitra A; Salvia R; Hruban RH; Bassi C; Capelli P; Lawlor RT; Goggins M; Scarpa A
J Pathol; 2014 Jul; 233(3):217-27. PubMed ID: 24604757
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical FAP Expression Reflects
Spektor AM; Gutjahr E; Lang M; Glatting FM; Hackert T; Pausch T; Tjaden C; Schreckenberger M; Haberkorn U; Röhrich M
J Nucl Med; 2024 Jan; 65(1):52-58. PubMed ID: 38167622
[TBL] [Abstract][Full Text] [Related]
12. Long-term Risk of Malignancy in Branch-Duct Intraductal Papillary Mucinous Neoplasms.
Oyama H; Tada M; Takagi K; Tateishi K; Hamada T; Nakai Y; Hakuta R; Ijichi H; Ishigaki K; Kanai S; Kogure H; Mizuno S; Saito K; Saito T; Sato T; Suzuki T; Takahara N; Morishita Y; Arita J; Hasegawa K; Tanaka M; Fukayama M; Koike K
Gastroenterology; 2020 Jan; 158(1):226-237.e5. PubMed ID: 31473224
[TBL] [Abstract][Full Text] [Related]
13. Loss of Pten and Activation of Kras Synergistically Induce Formation of Intraductal Papillary Mucinous Neoplasia From Pancreatic Ductal Cells in Mice.
Kopp JL; Dubois CL; Schaeffer DF; Samani A; Taghizadeh F; Cowan RW; Rhim AD; Stiles BL; Valasek M; Sander M
Gastroenterology; 2018 Apr; 154(5):1509-1523.e5. PubMed ID: 29273451
[TBL] [Abstract][Full Text] [Related]
14. Value of EUS in early detection of pancreatic ductal adenocarcinomas in patients with intraductal papillary mucinous neoplasms.
Kamata K; Kitano M; Kudo M; Sakamoto H; Kadosaka K; Miyata T; Imai H; Maekawa K; Chikugo T; Kumano M; Hyodo T; Murakami T; Chiba Y; Takeyama Y
Endoscopy; 2014 Jan; 46(1):22-9. PubMed ID: 24218310
[TBL] [Abstract][Full Text] [Related]
15. Long-standing diabetes mellitus increases concomitant pancreatic cancer risk in patients with intraductal papillary mucinous neoplasms.
Yamaguchi A; Tazuma S; Tamaru Y; Kusunoki R; Kuwai T; Kouno H; Toyota N; Sudo T; Kuraoka K; Kohno H
BMC Gastroenterol; 2022 Dec; 22(1):529. PubMed ID: 36539713
[TBL] [Abstract][Full Text] [Related]
16. Clinical assessment of the GNAS mutation status in patients with intraductal papillary mucinous neoplasm of the pancreas.
Ohtsuka T; Tomosugi T; Kimura R; Nakamura S; Miyasaka Y; Nakata K; Mori Y; Morita M; Torata N; Shindo K; Ohuchida K; Nakamura M
Surg Today; 2019 Nov; 49(11):887-893. PubMed ID: 30879148
[TBL] [Abstract][Full Text] [Related]
17. A pilot study to evaluate tissue- and plasma-based DNA driver mutations in a cohort of patients with pancreatic intraductal papillary mucinous neoplasms.
Park MA; Zaw T; Yoder SJ; Gomez M; Genilo-Delgado M; Basinski T; Katende E; Dam A; Mok SRS; Monteiro A; Mohammadi A; Jeong DK; Jiang K; Centeno BA; Hodul P; Malafa M; Fleming J; Chen DT; Mo Q; Teer JK; Permuth JB
G3 (Bethesda); 2023 Feb; 13(2):. PubMed ID: 36454217
[TBL] [Abstract][Full Text] [Related]
18. Loss of Trefoil Factor 2 From Pancreatic Duct Glands Promotes Formation of Intraductal Papillary Mucinous Neoplasms in Mice.
Yamaguchi J; Mino-Kenudson M; Liss AS; Chowdhury S; Wang TC; Fernández-Del Castillo C; Lillemoe KD; Warshaw AL; Thayer SP
Gastroenterology; 2016 Dec; 151(6):1232-1244.e10. PubMed ID: 27523981
[TBL] [Abstract][Full Text] [Related]
19. GNAS mutation is a frequent event in pancreatic intraductal papillary mucinous neoplasms and associated adenocarcinomas.
Hosoda W; Sasaki E; Murakami Y; Yamao K; Shimizu Y; Yatabe Y
Virchows Arch; 2015 Jun; 466(6):665-74. PubMed ID: 25796395
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of organoids derived from pancreatic intraductal papillary mucinous neoplasms.
Huang B; Trujillo MA; Fujikura K; Qiu M; Chen F; Felsenstein M; Zhou C; Skaro M; Gauthier C; Macgregor-Das A; Hutchings D; Hong SM; Hruban RH; Eshleman JR; Thompson ED; Klein AP; Goggins M; Wood LD; Roberts NJ
J Pathol; 2020 Nov; 252(3):252-262. PubMed ID: 32696980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]